MELBOURNE, AUSTRALIA--(Marketwire - December 05, 2007) - Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT), a biopharmaceutical company focused on the research and development of treatments for neurodegenerative disorders, today announced that the Company will host a panel discussion, in conjunction with Rodman and Renshaw, Oxford BioScience Partners, and other distinguished medical and scientific experts, at Oxford BioScience Partners, at 9:00 a.m. on December 10, 2007.
